Activation of Phosphatidylinositol 3-Kinase through Glycoprotein 130 Induces Protein Kinase B and p70 S6 Kinase Phosphorylation in Cardiac Myocytes*
Abstract
Phosphatidylinositol (PI) 3-kinase is known to be activated by cytokine stimulation through different types of receptors to transduce intracellular responses. We have previously reported that leukemia inhibitory factor (LIF) induces the activation of Janus kinase signal transducer and activator of transcription (JAK-STAT) and mitogen-activated protein (MAP) kinase pathways through glycoprotein (gp) 130 in cardiac myocytes. However, whether PI 3-kinase is involved in regulation of gp130 signaling and the activation mechanisms by which it associates with other tyrosine-phosphorylated proteins remain unknown. We found that LIF induced the activation of PI 3-kinase in cardiac myocytes. Moreover, JAK1 binds to PI 3-kinase, and LIF stimulation increases the PI 3-kinase activity in JAK1 immunoprecipitates. Activation of MAP kinase and protein kinase B by LIF was attenuated by wortmannin. LIF-induced p70 S6 kinase activation, protein synthesis, and c-fos mRNA expression were inhibited by wortmannin and rapamycin. Both inhibitors failed to appreciably affect the phosphorylation of STAT3. In conclusion, PI 3-kinase is activated with LIF in cardiac myocytes, and JAK1 is found to associate with this enzyme. PI 3-kinase provides a crucial link between gp130, MAP kinase, protein kinase B, and p70 S6 kinase in cardiac myocytes.
Footnotes
-
↵* This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan, grants from the Ministry of Health and Welfare of Japan, the Study Group of Molecular Cardiology, the Cell Science Research Foundation, and the Japan Heart Foundation:Pfizer Pharmaceutical Grant for Research on Coronary Artery Disease. Presented in part at the 70th Scientific Sessions of the American Heart Association, Orlando, FL, November 9–12, 1997, and published in abstract form (Oh, H., Fujio, Y., Kunisada, K., Hirota, H., Matsui, H., Kishimoto, T., Yamauchi-Takihara, K. (1997) Circulation 96, I-556).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ To whom correspondence should be addressed: Dept. of Medicine III, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka, Japan. Tel.: 81-6-879-3835; Fax: 81-6-879-3839; E-mail:takihara{at}imed3.med.osaka-u.ac.jp.
- Received September 24, 1997.
- Revision received February 9, 1998.
- The American Society for Biochemistry and Molecular Biology, Inc.











